Adaptimmune stock plunges after announcing Nasdaq delisting plans
LONDON - Third Point Investors Limited announced today it has completed the redemption of 4,376,750 ordinary shares at $28.56 per share, totaling approximately $125 million in initial consideration to shareholders.
The redemption, which was previously announced on September 4, leaves the investment company with 17,050,058 ordinary shares in issue and trading on the Main Market following the redemption date.
Shareholders who participated in the redemption will receive an additional deferred payment representing their portion of proceeds from what the company terms the "Illiquid Redemption Portfolio." This portfolio was valued at approximately $10 million as of August 31, 2025.
"Such net realisation proceeds will be paid to the relevant Redeeming Shareholder as soon as reasonably practicable following receipt of such realisation proceeds by the Company," Third Point stated in its press release.
The company noted it may defer payment of non-material sums to avoid administrative costs. The final value of the deferred consideration remains subject to change and will not be determined until each legacy investment in the portfolio is realized.
Following the redemption, Third Point’s total voting rights stand at 23,870,082, comprising 17,050,058 U.S. dollar ordinary shares and 6,820,024 U.S. dollar B shares, each carrying one vote per share. The company confirmed it holds no shares in treasury.
The announcement provides shareholders with updated figures for calculating disclosure requirements under the FCA’s Disclosure Guidance and Transparency Rules.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.